Management of chemotherapy-induced nausea, vomiting, oral mucositis, and diarrhoea.
about
Interventions for reducing diarrhoea in patients receiving chemotherapy for colorectal cancerSystemic treatment-induced gastrointestinal toxicity: incidence, clinical presentation and managementChemotherapy-Induced Constipation and Diarrhea: Pathophysiology, Current and Emerging TreatmentsMinimising treatment-associated risks in systemic cancer therapy.Chemotherapy induced diarrhea.Multicenter nonrandomized trial of ramosetron versus palonosetron in controlling chemotherapy-induced nausea and vomiting for colorectal cancer.The effects of body position on chemotherapy-induced nausea and vomiting: a single-blind randomized controlled trial.Development of the rat model of lapatinib-induced diarrhoea.The atypical cannabinoid O-1602 protects against experimental colitis and inhibits neutrophil recruitmentThe effects of fluorouracil, epirubicin, and cyclophosphamide (FEC60) on the intestinal barrier function and gut peptides in breast cancer patients: an observational study.Palonosetron in combination with 1-day versus 3-day dexamethasone for prevention of nausea and vomiting following moderately emetogenic chemotherapy: a randomized, multicenter, phase III trial.Oral mucositis induced by anticancer treatments: physiopathology and treatments.Single-dose palonosetron for prevention of chemotherapy-induced nausea and vomiting in patients with aggressive non-Hodgkin's lymphoma receiving moderately emetogenic chemotherapy containing steroids: results of a phase II study from the Gruppo ItalDouble-blind, placebo-controlled, randomized phase II study of TJ-14 (Hangeshashinto) for infusional fluorinated-pyrimidine-based colorectal cancer chemotherapy-induced oral mucositis.Significance of Kampo, traditional Japanese medicine, in supportive care of cancer patientsRole of Kampo medicine in integrative cancer therapy.Role of oxidative stress in oxaliplatin-induced enteric neuropathy and colonic dysmotility in mice.Preventive Effects of a Chinese Herbal Formula, Shengjiang Xiexin Decoction, on Irinotecan-Induced Delayed-Onset Diarrhea in Rats.HuangQin Decoction Attenuates CPT-11-Induced Gastrointestinal Toxicity by Regulating Bile Acids Metabolism Homeostasis.Efficacy of palonosetron (PAL) compared to other serotonin inhibitors (5-HT3R) in preventing chemotherapy-induced nausea and vomiting (CINV) in patients receiving moderately or highly emetogenic (MoHE) treatment: systematic review and meta-analysis.Targeting the endocannabinoid system for gastrointestinal diseases: future therapeutic strategies.Nosocomial diarrhea: a review of pathophysiology, etiology, and treatment strategies.SAMITAL®: a new botanical drug for the treatment of mucositis induced by oncological therapies.Platinum-based chemotherapy: gastrointestinal immunomodulation and enteric nervous system toxicity.Efficacy, safety and effectiveness of ondansetron compared to other serotonin-3 receptor antagonists (5-HT3RAs) used to control chemotherapy-induced nausea and vomiting: systematic review and meta-analysis.Irinotecan- and 5-fluorouracil-induced intestinal mucositis: insights into pathogenesis and therapeutic perspectives.Health Related Quality of Life (HRQoL) among Breast Cancer Patients Receiving Chemotherapy in Hospital Melaka: Single Centre ExperiencePerceptions and attitudes of Japanese gynecologic cancer patients to Kampo (Japanese herbal) medicines.Effect of SAMITAL® in the treatment of chemotherapy-induced mucositis in adult oncohematological patients.Management of gastrointestinal mucositis due to cancer therapies in pediatric patients: results of a case series with SAMITAL(®).Chemotherapy-induced intestinal inflammatory responses are mediated by exosome secretion of double-strand DNA via AIM2 inflammasome activation.Mouse mammary tumor virus promoter-containing retroviral promoter conversion vectors for gene-directed enzyme prodrug therapy are functional in vitro and in vivo.Matrix metalloproteinases are possible mediators for the development of alimentary tract mucositis in the dark agouti rat.Mitochondrial dysfunction and respiratory chain defects in a rodent model of methotrexate-induced enteritis.A Study on Utilization and Evaluation of Antiemetics in Chemotherapy-induced Nausea and Vomiting.Oxaliplatin-induced enteric neuronal loss and intestinal dysfunction is prevented by co-treatment with BGP-15.Effects of Oxaliplatin Treatment on the Myenteric Plexus Innervation and Glia in the Murine Distal ColonLactobacillus casei Variety rhamnosus Probiotic Preventively Attenuates 5-Fluorouracil/Oxaliplatin-Induced Intestinal Injury in a Syngeneic Colorectal Cancer Model.Cancer patients treated with intravenous chemotherapy for the first time. What are their needs? What do they lack? A qualitative-quantitative mixed approach
P2860
Q24203794-49C731BD-32DE-433B-B23A-8B1F5EF656B7Q26830695-846244C6-4E1B-4C9A-BDAE-C7878218FC77Q28079705-F62087C6-6269-4E0F-95D9-5DD33E90A07DQ33300964-61F25E9F-C99E-4712-A938-4DDB993F3EE1Q33307663-3481BA11-B582-43B2-83CA-850CA98A883EQ33879790-B47AFCD8-9F57-4B3C-8A36-2A5DC135E376Q33918271-8244E6C5-F05D-4F54-9532-C3F894588DAAQ33999288-E4802F84-03F0-4978-BE9B-62E2E02946BCQ34199383-166BDD27-C4C5-4F2D-A608-D0275791D031Q34573812-801D4EFE-7FEC-4245-9068-1A840CA33C73Q35082647-E93F4F39-B749-423F-B746-113A6555774EQ35166803-03C88DC2-E3E2-4F11-8F49-2C1429FA70A2Q35195231-9F029245-522C-4118-8176-33CEACA6CE79Q35799588-5BC3AF2A-61B1-4299-94CF-25647F1D3F28Q36990461-5932E801-A000-458A-963D-B48AF34B3D9DQ37044478-80158E34-50C5-45EC-8636-1F86C549E4DBQ37430558-9BDC85C1-A1FF-4FC5-BC89-204312DC9C0EQ37607371-C3771DE0-3715-4BC5-A7AB-B07FFA148E80Q37727573-30FE4B23-1108-4476-B9B9-0775BB59FDC3Q37760068-2F4BEB67-FA09-4376-85D8-C6E09DA186B4Q37960078-0CD77FA2-B28B-438F-ABF4-2B92BBF90A05Q37992488-1E23012D-D3FE-4208-BC90-F85F8F701676Q38155203-D8751B69-E57D-412F-BED5-1E2BDB8EF8DDQ38287054-45A2331C-9DC3-4878-B4BB-A66E8D41E645Q38834889-07A372DF-F856-4958-8604-0EAF8B02246FQ38945299-78DCE56C-FD5A-40C0-8126-19ED3FF8BB9DQ38999318-DED8AE34-03CF-4493-9A9A-FA7ECAE90F6BQ39263621-D2123F33-017A-421A-9122-2F17005C13E2Q39326895-624028A0-681B-417F-BE59-D3161A958923Q39520846-26706B75-05F3-431A-A4D0-52710698C9C1Q40242576-587F4444-9A7E-4F3C-9B35-4B11C447D079Q42137028-933D3C60-3BB4-418E-B699-4C80F553558EQ42947782-6CD3FF61-A0CF-400A-BAE3-974825C27C5DQ43979124-1E3F95E1-282B-4063-AC60-2F0F3E616FAFQ47112651-E7E4BBB3-B220-4FA5-B107-1BFFA32DD414Q47773940-9A30260E-EDF0-480C-8781-1B124EA66F75Q53058208-C1DE27C1-B8A2-4471-A33E-38C9038D9C7AQ55432763-14B827BF-E1E8-4E87-806B-80184F6F7FDFQ57073447-59638DCD-F59B-43A7-BF32-2EC4E8859FE6
P2860
Management of chemotherapy-induced nausea, vomiting, oral mucositis, and diarrhoea.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Management of chemotherapy-induced nausea, vomiting, oral mucositis, and diarrhoea.
@ast
Management of chemotherapy-induced nausea, vomiting, oral mucositis, and diarrhoea.
@en
type
label
Management of chemotherapy-induced nausea, vomiting, oral mucositis, and diarrhoea.
@ast
Management of chemotherapy-induced nausea, vomiting, oral mucositis, and diarrhoea.
@en
prefLabel
Management of chemotherapy-induced nausea, vomiting, oral mucositis, and diarrhoea.
@ast
Management of chemotherapy-induced nausea, vomiting, oral mucositis, and diarrhoea.
@en
P2093
P1433
P1476
Management of chemotherapy-induced nausea, vomiting, oral mucositis, and diarrhoea.
@en
P2093
Peter Tobin
Rohini Sharma
Stephen J Clarke
P304
P356
10.1016/S1470-2045(05)01735-3
P577
2005-02-01T00:00:00Z